The classification of epidermolysis bullosa (EB) into 3 main subtypes has been based on transmission electron microscopy (TEM) that is able to directly visualize and quantify specific ultrastructural features. Immunofluorescence antigenic mapping (IFM) is a technique that determines the precise level of skin cleavage by determining binding sites for a series of antibodies. To date, no study has compared the accuracy of these two techniques in diagnosing the major types of EB. A prospective cohort of 33 patients thought to have EB on clinical grounds had TEM, IFM, and genetic testing performed. The sensitivities and specificities of TEM and IFM were calculated compared with the genetic results. Of 33 cases, 30 had a positive EB diagnosis. TEM subclassified EB into its three major forms in 24/30 cases (80%) and IFM in 29/30 cases (97%). Overall, TEM sensitivities and specificities when compared with genetic results were 71% and 81%, respectively. IFM sensitivities and specificities when compared with genetic results were 97% and 100%, respectively. If a patient tested positive for EB by IFM, the likelihood ratio of having a particular type of EB was consistently greater than 20 against the reference standard (compared with a likelihood ratio less than 10 for TEM). Our results indicate that the diagnosis of EB is improved (sometimes substantially) by the use of IFM compared with TEM.
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Key Words: epidermolysis bullosa, electron microscopy, immunofluorescence mapping (Am J Dermatopathol 2006; 28:387-394) E pidermolysis bullosa (EB) is a group of inherited blistering diseases, which appear at birth, or shortly thereafter, and are characterized by trauma-induced blister formation. EB has been classified into three major groups based on the level within the skin where cleavage occurs when it leads to blister formation ( Table 1 ). In the simplex form of EB, blister formation occurs intraepidermally at the level of the basal keratinocytes, above the basement membrane zone (BMZ). Junctional forms of EB have blister formation within the lamina lucida and dystrophic EB (DEB) is characterized by blister formation in the sublamina densa. 1 The three main groups of EB are further classified into subtypes based on the clinical phenotype and genetic mode of transmission. 2 The development of immunoreagents to map antigens in the BMZ also facilitates the classification of EB into types and subtypes, 3 and helps direct mutation identification efforts in genetic studies.
It is generally difficult to accurately diagnose the type of EB occurring in a patient based on the clinical features alone, especially in the absence of a family history. A precise diagnosis, however, is crucial as the mode of inheritance, underlying pathology, cutaneous and extracutaneous manifestations and hence treatment and prognosis, varies widely between the subgroups of EB. Currently, there are three investigative modalities used in the diagnosis of EB and its subtypes; namely, transmission electron microscopy (TEM), immunofluorescence antigenic mapping (IFM), and genetic studies.
The main advantage of TEM is the ability to directly visualize and quantify specific ultrastructural features. IFM is a technique that has been developed by EB researchers as an alternative means of diagnosing EB. Over the last decades, a number of antigens have been identified in the BMZ, the majority of which represent individual BMZ molecules. 4 With IFM it is possible to infer the precise level of skin cleavage of a specimen by determining the site of binding by a series of antibodies directed to these BMZ antigens, which have known ultrastructural binding sites. 2 Antibodies directed against bullous pemphigoid antigen (BP 230), laminin, and type IV collagen were initially most commonly used to delineate the level of the blistering. More recently, antibodies to the proteins directly affected in EB such as to collagen VII, keratin 14, and laminin 5 are used. The technique, like TEM, involves taking a biopsy of a sample of clinically normal skin that has been gently rubbed to induce a microscopic cleavage.
Identification of the inherited gene defect(s) is the most definitive criterion. Mutation detection allows the prediction of clinical severity, phenotype, and natural history of the disease. 5, 6 Genetic studies also offer invaluable information for genetic counseling concerning the mode of inheritance and hence likelihood of recurrence in offspring. DNA-based prenatal testing in those with a known family history of EB is also possible. Apart from the diagnostic benefits for patients, there is a future possibility of gene therapy and other treatment modalities with genetic strategies. Nevertheless, genetic studies are still at the research and development stage. At this time, they are not widely available, are expensive, and the results take time to be produced. There are also a large variety of possible mutations that need to be screened, in most cases, adding to the length of studies and complexity of classification systems. Therefore, genetic testing is generally not considered a first line option in the diagnosis of EB subtypes.
As genetic studies are currently impractical, for complex cost issues, as first line investigation, TEM and IFM are the current first line techniques of choice for EB diagnosticians. While many authors have suggested that these two major techniques are equal in their diagnostic sensitivity and specificity, 7, 8 no studies to date have tested this hypothesis on the wide range of EB subtypes. To test this hypothesis, we studied a prospective cohort of patients thought to have EB on clinical grounds who had both investigations performed and compared the results of these techniques with the genetic results and final diagnoses, as defined below, to determine which technique produced the most accurate, reproducible, and reliable results.
MATERIALS AND METHODS
EB cases were collected prospectively from the patients referred for IFM and TEM testing, approved by the South Eastern Sydney Area Health Service Ethics Committee. Testing was conducted over a 5-year period. The 33 cases comprised 17 females and 16 males aged 2 days to 70 years (average 13 y) (Table 2) from the multidisciplinary EB Clinic at Sydney Children's Hospital, the adult EB clinic at St George Hospital, Sydney (the latter both staffed by Professor Murrell) or interstate EB clinics. In each patient, the dermatologist made a clinical diagnosis of possible and/or probable EB, and IFM and TEM were performed on their skin sample.
Skin Biopsies
To perform the biopsies consistently, a protocol was developed that was used in all cases. A clinically normal area of the patient's skin was rubbed with a vertically oriented pencil eraser in a tortional fashion for about 2 minutes or until the area turned red. The purpose of biopsying clinically normal skin is to avoid the appearance of secondary changes of injury and wound healing that occur in biopsies of old blisters and hence minimize the difficulty of identifying the correct cleavage plane. If the area turned red within a few minutes the biopsy was performed straight away. If not, the patient was asked to return in 1 hour or later when it was either red or a blister developed. The area was anesthetized and a small elliptical incision of the area performed. This was inverted on gauze and cut into 3 pieces: 1 was put into formalin for routine hematoxylin and eosin staining, 1 into Michel's medium for IFM, and 1 in fresh buffered glutaraldehyde for TEM. In a minority of cases (6/33), written instructions, consent forms, and appropriate media were sent to other institutions interstate for the referring dermatologist to obtain the biopsies.
IFM Procedure
The specimens were mounted in optimal cutting temperature and oriented to demonstrate a transverse section through the full thickness of skin. Five micron frozen sections were cut. Frozen sections of normal skin were also cut to act as a positive control. Each of the 13 monoclonal antibodies (listed in Table 3 ) was applied to a section of patient and normal skin. All sections were then washed in phosphate buffered saline buffer and a secondary antimouse fluorescein isothiocynate conjugate was applied for 30 minutes. After a final wash in phosphate buffered saline, the slides were mounted then viewed through a fluorescence microscope and photographed ( Fig. 1 ).
TEM Procedure
In the majority of cases, TEM was performed in the TEM unit at St George Hospital Anatomical Pathology Department. In some cases, the results for TEM were obtained by reviewing the reports and TEM pictures obtained from the other testing laboratories. The TEM pictures were read by 1 of the 2 anatomic pathologists skilled in electron microscopy with the assistance of the dermatologist. When the diagnosis by TEM was unclear, pictures were also reviewed by Dr Jo-David Fine, an expert on TEM of the skin in EB, based at the National EB Registry in the United States. In some cases, where the TEM was inconclusive but IFM had a clear- cut result that agreed with the clinical/genetic findings, a further skin biopsy for repeat TEM was performed. These repeated analyses were not used in the statistical analysis because their interpretation was biased and did not reflect the usefulness of the test for initial diagnosis.
For TEM samples, the skin biopsies were immediately placed in 2.5% glutaraldehyde buffered with 0.1 M sodium cacodylate buffer for 3 hours at 4°C after being dissected into 1 mm cubes to achieve optimum fixation. The specimens were subsequently washed in 3 changes sodium cacodylate buffer (3 3 20 min) then postfixed in 1% osmium tetroxide for 1 hour at room temperature. After fixation, specimen were dehydrated through ascending grades of ethanol, and then en bloc stained with 2% uranyl acetate in 1:1 ethanol-acetone for 2 hours followed by 2 washes with absolute acetone (for 30 min each). Impregnation with resin was achieved using 1:1 acetone/ Spurrs epoxy resin for 4 hours, 2:1 resin/acetone for 4 hours, and full-strength resin for 8 hours before polymerization. The samples were oriented in coffin moulds such that a transverse section across the full thickness of skin was attained. Semithin sections of the embedded blocks were cut on an Ultracut S (or E) Ultramicrotome (Reichart-Jung) and stained with Tolui-dine Blue. These sections were examined under a light microscope to ascertain the area of interest. Once the appropriate area has been identified, ultra-thin sections were cut and mounted on copper grids. Sections were allowed to dry then stained with 4% alcoholic uranyl acetate (20 to 24min), then differentiated in 50% ethanol and washed in 4 changes deionized water (25 dips each). After drying, sections were placed in 0.1% to 0.4% lead citrate (3 min) and then washed in 3 changes of CO 2 -free water. Once again the sections were dried ready for examination under the transmission electron microscope at an accelerating voltage of 75 kV.
Genetic Studies
Informed consent (under a protocol approved by the South East Sydney Area Health Service) was obtained before blood samples were taken from the probands and their firstdegree relatives. Genomic DNA was extracted. Keratin mutation studies were conducted in our laboratory and/or in collaboration with Sandra Klingberg at the Royal Brisbane Hospital Pathology Service. Collagen VII (COL7A1), laminin V (LAMB3, LAMC2, and LAMA3), and integrin (ITGA6 and ITGB4) mutation screening was performed by Dr Ellen Pfendner and Prof Jouni Uitto at Jefferson Medical College, Philadelphia, and confirmed by Sandra Klingberg in a clinical genetics laboratory in Brisbane, Australia.
Reference Standards
The genetic diagnosis was considered the definitive diagnosis when determining the accuracies of IFM and TEM diagnoses of the main types of EB [EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB)]. At the time the results were compared for statistical analysis, 23/30 EB patients had received their genetic results. The term ÔÔfinal diagnosisÕÕ was defined as the genetic result, where available, or agreement between the IFM and TEM result, where genetic results were not available. In cases where IFM and TEM results did not agree, the genetic result was considered to confirm the diagnosis. When interpreting the IFM and TEM results, a ÔÔnormalÕÕ result was defined as no evidence of any abnormality in the given specimen. An ÔÔinconclusiveÕÕ result was assigned to cases where abnormalities were present, but there was insufficient evidence for diagnosing a particular type of EB (ie, EBS, JEB, or DEB). In analyzing our data, inconclusive cases were considered to be false positives. In some cases, the investigations were able to specifically diagnose the subtype of EB [eg, JEB-Herlitz vs. JEB non-Herlitz (JEB-nH)]. These results were included in Table 2 but were not the focus of our statistical analysis.
Statistical Analysis
The following diagnostic characteristics of IFM and TEM were calculated: sensitivity (the proportion of diseased individuals who are correctly identified as such), specificity (the proportion of nondiseased individuals who are correctly identified as such), positive and negative predictive values (the proportion of individuals testing positive or negative who are diseased or nondiseased, respectively), positive and negative likelihood ratios (the ratio of the probability of a positive or negative test result, respectively, in diseased individuals against the probability of the same test result in nondiseased individuals), and the diagnostic odds ratio (the ratio of the odds of a positive test result in diseased individuals against the odds of the same test result in nondiseased individuals). Calculations for the last 3 outcomes applied Yates' correction. All 95% confidence intervals were calculated using exact procedures.
RESULTS
Of the 33 cases investigated, 30 cases had a positive EB diagnosis (EBS 13; JEB 11; and DEB 6). Overall TEM examination subclassified EB into its three major forms in 24/30 (80%) cases and IFM examination in 29/30 (97%) cases ( Table 2 ). In the 3 cases where EB was thought possible by clinical criteria (cases 10, 28, and 29), all IFM and TEM results were reported as normal. The genetic results were available to confirm the diagnosis for 23 of the EB patients, including 7 cases where the IFM and TEM results did not agree. In 4 of these cases, TEM studies were inconclusive, in 2 cases TEM studies were reported as normal, and in another case the TEM result differed from the IFM result. In 6 of 7 cases, a positive IFM result agreed with the genetic result. In 100% of cases where TEM and IFM gave the same diagnosis and genetics data were available, all three techniques were in agreement. In addition, in 11 cases, IFM correctly identified the specific subtype of EB (eg, JEB-Herlitz vs. JEB-nH vs. JEB pyloric atresia), whereas TEM was only able to do so in 1 case.
Although statistical significance was not attained, IFM showed consistently higher sensitivity, specificity, and predictive values in the diagnosis of all three subtypes of EB compared with TEM, regardless of the reference standard used ( Table 4 ). In addition, positive likelihood ratio values for IFM were consistently above 20 across all EB subtypes and reference standards, implying a substantial increase in the posttest odds of disease for a positive result on IFM given particular pretest odds.
DISCUSSION
Our findings suggest that TEM and IFM are not equally accurate and sensitive as diagnostic tests for the major types of EB. A recent study comparing TEM with immunohistochemical analysis of formalin-fixed skin specimens stained with only three monoclonal antibodies to keratin, laminin 1, and type IV collagen found this version of mapping to be inferior to TEM, with TEM diagnostic in 37/39 (95%) cases and immunohistochemistry in 33/39 (85%) cases. 9 The relatively lower sensitivity of this type of immunohistochemistry may have been related to the lack of antibody staining, in some cases, after formalin fixation and processing which can change the conformation of proteins. They used the less specific pankeratin antibody for keratin, rather than more specific antibodies directed at specific proteins that can be missing or reduced, for example, in severe recessive forms of EB, such as collagen VII in recessive DEB Hallopeau-Siemens and laminin V b3 in Herlitz JEB. 10 Our immunofluorescence mapping used a larger variety of antibodies directed at more specific binding sites (Table 3 ) and hence in our prospective study, IFM was overall more specific and sensitive as a diagnostic test for subclassifying EB.
Although our results failed to reach statistical significance, it represents the largest prospective Australian collection of a broad spectrum of EB cases diagnosed simultaneously using IFM and TEM with confirmation through genetic testing. Assuming that we wish to detect a 10% difference in sensitivity between TEM and IFM (both compared with genetic results), we will require approximately 92 cases based on the results for EBS presented in this study. Our institution is a major specialist referral center for EB in Australia, including the most severe presentations. At the patient recruitment rate and assuming no refusals, withdrawals, or losses to follow-up, sample size requirements will imply continued accrual over the next decade. The advantage offered by well-funded multicenter trials of this nature is obvious.
Despite the overlapping confidence intervals (which is expected to disappear with increasing sample size), the consistency of the direction of effects is undeniable. Across all EB subtypes, a higher proportion of cases are correctly classified as a particular type of EB based on IFM compared with TEM. In addition, the probability that a test result accurately reflects disease status in a patient is uniformly greater for IFM than TEM. Although it is premature to suggest that IFM replace TEM as the standard diagnostic method in the differentiation of EB, our results certainly suggest that the accuracy of both tests is nonequivalent.
Besides the accuracy of TEM and IFM as diagnostic tests for EB, there are other practical issues to consider regarding their use in clinical practice. While TEM remains the only method by which the presence or absence of clumped tonofilaments can be assessed, 2 it also has several disadvantages. Firstly, TEM requires a relatively long training period, both for sample preparation and for ultrastructural interpretation. Sample preparation for TEM is also more labor intensive, taking several days to weeks to complete a single study, adding to the cost of this investigation. ATEM specialist also needs to be allied with a dermatologist who has a substantial EB caseload to acquire enough experience to make a reliable TEM-based differential diagnosis. For this reason, relatively few personnel have the level of expertise required for proper preparation of the EB biopsy and interpretation of the results. Hence, it is not surprising, that this technique is not widely available.
Secondly, even for the experienced TEM specialist, the interpretation of specimens is often difficult. Only a very small part (,1 mm 2 area 3 2 ,1 micron thickness) of the biopsy is usually visualized in each prepared specimen, so the blister could be missed. On such small sample sizes, it is easy to overestimate or under-estimate the numbers of fibrils and other structural components in EB. At very high magnifications, artifactual space can be misinterpreted as the cleavage site. Nonspecific dense bundles of keratin filaments may be misinterpreted as clumped tonofilaments (and consequently misdiagnosed as EBS Dowling-Meara). In our study, there were 7 cases in which TEM results differed from IFM results. In 5 out of 7 cases, no blisters were present in the samples obtained. In the absence of cleavage, the interpretation of TEM studies is more difficult, whereas IFM studies do not depend so heavily on the presence of a cleavage plane.
It is also often difficult to accurately diagnose the various subsets of EB by TEM because the ultrastructural findings can vary. For instance, JEB is characterized by fewer hemidesmosomes and abnormal subbasal dense plates than in normal skin. However, detailed morphometric analysis has shown that there is marked heterogeneity of the hemidesmosomes in JEB, and that they may even be normal, 11 especially in cases of JEB-nH. 2 In DEB, the main ultrastructural abnormality lies in the number of anchoring fibrils, but variations in numbers of anchoring fibrils are difficult to quantify. Morphometric analysis has shown a total absence of anchoring fibrils in severe recessive generalized DEB. 12 On IFM, the latter is clear-cut as there is negative staining with antibodies to collagen VII in recessive DEB Hallopeau-Siemens. In this study, there were several cases of JEB and DEB in which the TEM result did not agree with the IFM result. In the 4 cases where TEM results were reported as inconclusive, genetic studies confirmed 3 cases to be JEB-nH and 1 case to be RDEB. These examples are consistent with the observed lower sensitivity and specificity of TEM compared with IFM in the diagnosis of JEB and DEB. The subtypes EBS Koebner and EBS Weber-Cockayne cannot be accurately differentiated with TEM or IFM and is made instead on clinical grounds. One study showed that the ultrastructural features seen in TEM were inconsistent between patients suffering from EBS Koebner, EBS Weber-Cockayne, and EBS Dowling-Meara, with some patients having features within ranges observed in normal skin. 13, 14 In 2 of our EBS cases confirmed by genetic studies, the TEM results were reported as normal.
There are many advantages of immunofluorescence mapping especially when compared with electron microscopy. Firstly, IFM is far more convenient and accessible. The technique involves an inexpensive, chemically stable, and widely available transport medium: Michel's solution. Specimens placed in this medium can be evaluated weeks after the biopsy was taken without compromising the quality of the tissue, and hence the interpretation of results (Fine, personal communication, 1998). Secondly, the procedure is relatively cheap to perform, as most of the reagents and equipment used are already available in most laboratories involved in routine immunofluorescence testing. Thirdly, and of considerable benefit, the mapping can be completed within a few hours of obtaining a specimen, as opposed to the several days to weeks required for most TEM studies. 2 However, not all the antibodies used are commercially available and some need to be obtained from research laboratories ( Table 3 ).
The preparation of tissues for IFM also allows for further, or later, evaluation with additional monoclonal antibodies proven to be extremely useful in the diagnosis of specific subsets of EB. Even though IFM does not permit the direct visualization of the basement membrane and associated ultrastructural components, many features can be accurately assessed indirectly. The technique has in fact contributed greatly to our understanding of skin fragility. By identifying the various staining patterns of certain antigen-antibodies, abnormalities of the structural proteins responsible for the blister formation have been identified. 8 Further research has linked these structural proteins to the various underlying genes, which has aided greatly in the genetic testing of EB patients and their family members. 15 Briefly, in EBS, staining for collagen IV demonstrates binding to the floor of the blister. 3 IFM is particularly useful in identifying the subtype EBS with muscular dystrophy. Antibody staining reveals an absence or reduction of plectin along the BMZ in such cases. 16 This knowledge has helped identify the underlying genes responsible for the plectin abnormality. 17 In JEB, staining for keratin is found in the roof, and staining for type IV collagen and laminin in the floor, of the blister. 18 Further subtyping of JEB can be achieved through the addition of various antibodies. The monoclonal GB3 antibody forms the basis for identifying, along with clinical parameters, the Herlitz variety of JEB, with staining absent or markedly reduced. [19] [20] [21] The GB3 antibody identifies the antigen laminin-5, which is the major component of anchoring fibrils and has 3 subunits-a3, b3, and g2. 22 Specific antibodies directed against these subunits have subsequently been developed, which has again assisted in the identification of genes responsible for these mutations. 12 In our study, TEM has a lower sensitivity for the diagnosis of JEB (60% against genetic diagnosis; 64% against final diagnosis) than for other forms of EB. In the JEB cases where the TEM results were discordant to the IFM and/or genetic results, 1 case was reported as dystrophic (1/3) and 2 cases as inconclusive (2/3) as there was no blistering and no abnormalities detected in the anchoring filaments and hemidesmosomes in these cases.
In the non-Herlitz variety of JEB, which includes generalized atrophic benign JEB and mitis JEB, there is reduced or absent expression of the 180-kd bullous pemphigoid antigen 2 in the BMZ 15 or reduction in expression of Laminin V B3. In a rare form of JEB associated with pyloric atresia, there is reduced antigenic expression of the a6b4 integrins, when measured by the hemidesmosome associated b4 subunit antibody, G71. [23] [24] [25] [26] In this study, 2/33 cases had clinically apparent pyloric atresia, which has been reported in association with JEB subtypes but also with several other forms of EB. 27 Both the IFM and TEM confirmed JEB in both cases, but only the IFM was able to identify a lack of production of b4 integrin, which allowed screening of the appropriate gene, for JEB pyloric atresia. Several of these cases formed the basis of molecular testing that revealed new mutations in ITGB4 and LAMB3. 6 Finally, in DEB staining for type IV collagen, laminin, and bullous pemphigoid antigen are localized to the roof of the blister. 11, 18 Antigenic mapping in DEB cases is aimed at collagen type VII. 28, 29 In line with this observation, genetic testing has demonstrated mutations in the collagen VII gene, COL7A1. 12 Thus, IFM is a useful investigative tool in differentiating between the various subtypes of EB. It is rapidly and easily performed and provides important information about the structural integrity of the BMZ. The main disadvantage of IFM is that information about specific macromolecular defects has to be inferred because the defects themselves cannot be directly visualized at the light microscopic level. This would affect the accurate diagnosis of relatively few EBS variants such as Dowling-Meara. However, the accuracy of IFM in determining the major type and often subtypes, of EB is equivalent if not superior to TEM, as shown in this study, in particular with regards to the diagnosis of JEB and DEB types. IFM is also helpful in directing genetic mutation identification especially given that this latter technique is not currently q 2006 Lippincott Williams & Wilkins practical as a first line investigation. Hence, IFM is a useful alternative test to TEM and should be performed in conjunction with TEM if possible. If TEM is not available, then IFM is a useful and reliable alternative.
